| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |